Skip to content

PASITHEA THERAPEUTICS CORP.

KTTA KTTAW

CIK 0001841330

← back to feed
Revenue (TTM)
$486.56K
+3,130.4% YoY Q1 May 2026
Net Income (TTM)
−$13.19M
−46.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.80
+77.1% YoY Q1 May 2026
Gross Margin
-0.5%
Q1 May 2026
Operating Margin
-3,181.1%
Q1 May 2026
Net Margin
-2,710.1%
Q1 May 2026
Free Cash Flow (TTM)
−$14.73M
Q1 May 2026
Cash
$50.4M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
33.41M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings